Johoon Kim

Johoon Kim

Auto-generated profile, based on publicly available information

Johoon Kim

Departments of Radiology, Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LGLiang Guo
Liang Guo
HAHirokuni Akahori
Hirokuni Akahori
EHEmanuel Harari
Emanuel Harari
SSSamantha L. Smith
Samantha L. Smith
RPRohini Polavarapu
Rohini Polavarapu
AFAloke V. Finn
Aloke V. Finn
Intake of hemoglobin by the hemoglobin-haptoglobin receptor CD163 leads to a distinct alternative non–foam cell antiinflammatory macrophage phenotype that was previously considered atheroprotective. Here, we reveal an unexpected but important pathogenic role for these macrophages in atherosclerosis. Using human atherosclerotic samples, cultured cells, and a mouse model of advanced atherosclerosis, we investigated the role of intraplaque hemorrhage on macrophage function with respect to angiogenesis, vascular permeability, inflammation, and plaque progression. In human atherosclerotic lesions, CD163+ macrophages were associated with plaque progression, microvascularity, and a high level of HIF1α and VEGF-A expression. We observed irregular vascular endothelial cadherin in intraplaque microvessels surrounded by CD163+ macrophages. Within these cells, activation of HIF1α via inhibition of prolyl hydroxylases promoted VEGF-mediated increases in intraplaque angiogenesis, vascular permeability, and inflammatory cell recruitment. CD163+ macrophages increased intraplaque endothelial VCAM expression and plaque inflammation. Subjects with homozygous minor alleles of the SNP rs7136716 had elevated microvessel density, increased expression of CD163 in ruptured coronary plaques, and a higher risk of myocardial infarction and coronary heart disease in population cohorts. Thus, our findings highlight a nonlipid-driven mechanism by which alternative macrophages promote plaque angiogenesis, leakiness, inflammation, and progression via the CD163/HIF1α/VEGF-A pathway.

28 July 2020 in ACS Nano
Verified
Journal Article
Closed access
PNPratap C. Naha
Pratap C. Naha
JHJessica C. Hsu
Jessica C. Hsu
JKJohoon Kim
Johoon Kim
SSShrey Shah
Shrey Shah
MBMathilde Bouché
Mathilde Bouché
DCDavid P. Cormode
David P. Cormode

4 November 2019 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MBMathilde Bouché
Mathilde Bouché
JHJessica C. Hsu
Jessica C. Hsu
YDYuxi C. Dong
Yuxi C. Dong
JKJohoon Kim
Johoon Kim
KTKimberly Taing
Kimberly Taing
DCDavid P. Cormode
David P. Cormode

18 May 2017 in Bioconjugate Chemistry
Verified
Journal Article
Open access
JKJohoon Kim
Johoon Kim
PCPeter Chhour
Peter Chhour
JHJessica Hsu
Jessica Hsu
HLHarold I. Litt
Harold I. Litt
VFVictor A. Ferrari
Victor A. Ferrari
DCDavid P. Cormode
David P. Cormode
Efforts to develop novel cell-based therapies originated with the first bone marrow transplant on a leukemia patient in 1956. Preclinical and clinical examples of cell-based treatment strategies have shown promising results across many disciplines in medicine, with recent advances in immune cell therapies for cancer producing remarkable response rates, even in patients with multiple treatment failures. However, cell-based therapies suffer from inconsistent outcomes, motivating the search for tools that allow monitoring of cell delivery and behavior in vivo. Noninvasive cell imaging techniques, also known as cell tracking, have been developed to address this issue. These tools can allow real-time, quantitative, and long-term monitoring of transplanted cells in the recipient, providing insight on cell migration, distribution, viability, differentiation, and fate, all of which play crucial roles in treatment efficacy. Understanding these parameters allows the optimization of cell choice, delivery route, and dosage for therapy and advances cell-based therapy for specific clinical uses. To date, most cell tracking work has centered on imaging modalities such as MRI, radionuclide imaging, and optical imaging. However, X-ray computed tomography (CT) is an emerging method for cell tracking that has several strengths such as high spatial and temporal resolution, and excellent quantitative capabilities. The advantages of CT for cell tracking are enhanced by its wide availability and cost effectiveness, allowing CT to become one of the most popular clinical imaging modalities and a key asset in disease diagnosis. In this review, we will discuss recent advances in cell tracking methods using X-ray CT in various applications, in addition to predictions on how the field will progress.

16 December 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JKJohoon Kim
Johoon Kim
GHGwanui Hong
Gwanui Hong
LMLuda Mazaleuskaya
Luda Mazaleuskaya
JHJessica C. Hsu
Jessica C. Hsu
DRDerick N. Rosario-Berrios
Derick N. Rosario-Berrios
DCDavid P. Cormode
David P. Cormode

21 April 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
EHElizabeth M. Higbee-Dempsey
Elizabeth M. Higbee-Dempsey
AAAhmad Amirshaghaghi
Ahmad Amirshaghaghi
MCMatthew J. Case
Matthew J. Case
MBMathilde Bouché
Mathilde Bouché
JKJohoon Kim
Johoon Kim
ATAndrew Tsourkas
Andrew Tsourkas